- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/564 - ImmunoassayBiospecific binding assayMaterials therefor for pre-existing immune complex or autoimmune disease
Patent holdings for IPC class G01N 33/564
Total number of patents in this class: 2237
10-year publication summary
186
|
220
|
185
|
176
|
169
|
155
|
146
|
137
|
116
|
55
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Mayo Foundation for Medical Education and Research | 3188 |
34 |
The Johns Hopkins University | 5642 |
32 |
EUROIMMUN Medizinische Labordiagnostika AG | 224 |
29 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3360 |
29 |
The Regents of the University of California | 19812 |
27 |
The Board of Trustees of the Leland Stanford Junior University | 6365 |
27 |
Prometheus Laboratories Inc. | 93 |
24 |
Oklahoma Medical Research Foundation | 159 |
23 |
iNova Diagnostics, Inc. | 64 |
21 |
CellTrend GmbH | 29 |
19 |
F. Hoffmann-La Roche AG | 7926 |
18 |
Laboratory Corporation of America Holdings | 823 |
17 |
The Board of Regents of the University of Texas System | 2199 |
17 |
Genentech, Inc. | 3961 |
15 |
Centre National de La Recherche Scientifique | 10321 |
15 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2765 |
14 |
Institut Pasteur | 789 |
13 |
Yeda Research and Development Co. Ltd. | 1327 |
13 |
The General Hospital Corporation | 4704 |
12 |
Allegheny-Singer Research Institute | 90 |
12 |
Other owners | 1826 |